Decompensated Heart Failure Clinical Trial
Official title:
NT-BNP Guided Care in Addition to Multidisciplinary Care in Patients With Chronic Heart Failure A Three-Arm, Prospective, Randomised Study
Verified date | July 2006 |
Source | Medical University of Vienna |
Contact | n/a |
Is FDA regulated | No |
Health authority | Austria: Federal Ministry for Health and Women |
Study type | Interventional |
HF is associated with repeated hospitalisations and poor prognosis.The aim of this study is
to investigate whether BNP-guided care (BGC) in addition to multidisciplinary management(MM)
improves outcome compared to HNC alone or usual care (UC) for decompensated HF patients
after discharge.
Patients hospitalised with cardiac decompensation in 9 Viennese hospitals are randomised to
BGC, MM alone, or UC. MM includes 2 consultations of a heart failure (HF) specialist 10 days
and 2 months after discharge for recommending medical optimisation and care by a specialised
HF nurse including 4 home visits and telephone contact. In addition, BGC includes
intensified increase of medical treatment during repeated follow-up visits in a HF clinic in
patients with an Nt-BNP level above 2200pg/ml at discharge.
Status | Terminated |
Enrollment | 0 |
Est. completion date | September 2005 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 19 Years and older |
Eligibility |
Inclusion Criteria: 1. Clinical signs and symptoms of cardiac decompensation during the present hospitalisation 2. NYHA class III or IV at time of admission 3. Cardiothoracic ratio > 0.5, and/or left ventricular ejection fraction <40% documented by echocardiography Exclusion Criteria: |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Medical University of Vienna |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Heart failure rehospitalisation rate; | |||
Primary | combined endpoint death or heart failure rehospitalisation; |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05910437 -
Optimizing Treatments for Heart Failure During Hospitalization
|
||
Active, not recruiting |
NCT03701880 -
Early Use of Ivabradine in Heart Failure
|
N/A | |
Recruiting |
NCT03157219 -
Manipal Heart Failure Registry (MHFR)
|
N/A | |
Recruiting |
NCT06114498 -
Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction
|
||
Completed |
NCT03838003 -
Exercise in Patients Admitted With Recently Decompensated Heart Failure
|
N/A | |
Completed |
NCT02997462 -
Monocyte Phenotypic Changes in Heart Failure
|
||
Completed |
NCT04493346 -
Shear Wave Elastography
|
||
Recruiting |
NCT02666651 -
Regional Tolvaptan Registry
|
Phase 4 | |
Recruiting |
NCT02236247 -
Control of Sinus Node Tachycardia as an Additional Therapy in Patients With Decompensated Heart Failure
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06273397 -
Acetazolamide or Metolazone in Acute Heart Failure
|
N/A | |
Completed |
NCT05927285 -
Effect on Kidney Function Recovery Guiding Decongestion With VExUS in Patients With Cardiorenal Syndrome 1
|
N/A | |
Withdrawn |
NCT04572867 -
Aquapheresis Efficacy in Outpatients With Decompensated Heart Failure
|
N/A | |
Completed |
NCT02157506 -
A Dose Ranging Phase IIa Study of 6 Hour Intravenous Dosages of CXL-1427 in Patients Hospitalized With Heart Failure
|
Phase 2 | |
Recruiting |
NCT03914222 -
Comparing PA Compliance During and After Decompensation in HFP
|
N/A | |
Recruiting |
NCT06286423 -
Colchicine in Acutely Decompensated HFREF
|
Phase 4 | |
Recruiting |
NCT03009552 -
Speckle Tracking Echocardiography Adds Information in Decompensated Heart Failure
|
N/A | |
Completed |
NCT04019314 -
Assessment of ProEnkephalin to Detect Acute Kidney Injury (AKI)
|
N/A | |
Recruiting |
NCT02649517 -
Clinical and Morphological Characteristics of Chronic Inflammation in the Myocardium in Patients With Decompensated HF With Ischemic Systolic Dysfunction
|
N/A | |
Recruiting |
NCT03440970 -
Mechanism and Effects of Manipulating Chloride Homeostasis in Stable Heart Failure
|
Early Phase 1 | |
Recruiting |
NCT05090930 -
Innovative Technologies for the Treatment of Pulmonary and Heart Failure
|
N/A |